INEGY 10 MG80 MG TABLETS

Država: Izrael

Jezik: engleski

Izvor: Ministry of Health

Aktivni sastojci:

EZETIMIBE; SIMVASTATIN

Dostupno od:

MERCK SHARP & DOHME ISRAEL LTD

ATC koda:

C10AA01

Farmaceutski oblik:

TABLETS

Sastav:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Administracija rute:

PER OS

Tip recepta:

Required

Proizveden od:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapijska grupa:

SIMVASTATIN

Područje terapije:

SIMVASTATIN

Terapijske indikacije:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Datum autorizacije:

2012-04-30